How this company is giving hope for challenging neurological treatments

Looking at slides of the blood-brain-barrier. , Image courtesy of Market One Media
  • Effective treatment of neurological conditions continues to be challenging
  • Propelled by revolutionary breakthroughs in blood-brain barrier drug delivery, Bioasis Technologies brings new insights to the forefront
  • With tech partnerships, Bioasis has secured research funding for selected development programs and potentially lucrative milestone payments

“We’re going after a solution where currently none exists right now.”

— Dr. Deborah Rathjen, Executive Chair, Bioasis Technologies Inc.

Brain slides from Bioasis’s xB3 ™ platform.
Patient going in for a brain scan.
The blood-brain barrier (BBB) is a highly selective barrier that separates circulating blood from the brain and extracellular fluid in the central nervous system.



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Market One

Market One

Canada’s leading marketing agency for public companies.